Status:
RECRUITING
Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands
Lead Sponsor:
University of California, Davis
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to better understand the neural correlates of higher-order cognition, both in the healthy brain and in schizophrenia, and to determine how these mechanisms are modulated b...
Eligibility Criteria
Inclusion
- between ages of 18 and 50
- ability to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks
- ability to give valid informed consent
Exclusion
- no history of head trauma
- no current or previous history of treatment with psychotropic medication
- corrected vision 20/30 or better
- tDCS/MRI contraindications, including: pregnancy, ferrous metal in any part of the body, serious medical conditions, claustrophobia, metallic implants, skin damage, conditions such as eczema at electrode sites, cranial pathologies
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04885322
Start Date
April 14 2021
End Date
June 30 2027
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imaging Research Center
Sacramento, California, United States, 95817